Treatment of vasomotor symptoms and hot flashes, Night Sweats with sex steroid precursors in combination with selective estrogen receptor modulators. Pharmaceutical composition. Set of elements.

摘要

Methods to reduce or eliminate respiratory diseases, vascular symptoms and late sweating, reduce the risk of breast cancer, uterine cancer or endometrial cancer, and have beneficial effects by inhibiting the development of osteoporosis, high cholesterol, hyperlipidemia and allergies, Hypertension, insulin resistance, type 2 diabetes, muscle mass loss, fat, Alzheimer's disease, cognitive loss, memory loss or vaginal dryness, including the use of large amounts of sex steroid precursors in susceptible blood animals, including humans,Especially dehidropiandrosterona (DHEA),An antibiotic or selective modulator of an estrogen receptor, especially a compound of general structure (1). ILO Convention No. 3: a drug synthesis aimed at reducing or eliminating certain symptoms, including asphyxia, vascular symptoms and late sweating, characterized by: (a) a precursor, diluent or acceptable drug vehicle; (b) production of at least one sex steroid precursor or one sex steroid; (c) At least one selective modulator of estrogen receptor or anti estrogen receptor or product of any one of them;en donde dicha composicion farmac utica se provee en un envase que dirige el uso de dicha composicion en la reduccion o eliminacion de al menos un s ntoma seleccionado del grupo que consiste de sofocos s ntomas vasomotores y sudores nocturnos Reivindicacion 35 La composicion farmac utica de la SH 646 Pipendoxifeno (ERA 923)Bazedoxifeno (TSE 424 WAY 140424)Oboria (hormone) and a centaur derivative.